•A 2026 meta-analysis found that longer preparation and integration sessions in psilocybin-assisted therapy are linked to larger antidepressant effects.

•Preparation helps to establish a strong therapeutic alliance, set intentions, and manage expectations for the psychedelic experience.

•Integration is the process of making sense of the psychedelic experience and incorporating its insights into one's daily life.

•The study highlights the need for standardized protocols in psilocybin-assisted therapy to optimize outcomes.

•Non-manualized psychotherapy, which allows for a more flexible and individualized approach, was also associated with larger antidepressant effects.

In the rapidly evolving landscape of psychedelic medicine, the focus is often on the profound and transformative power of the psychedelic experience itself. However, a crucial and often overlooked aspect of this therapy is the work that happens before and after the dosing session. A 2026 systematic review and meta-analysis published in Neuroscience & Biobehavioral Reviews sheds light on this critical component, revealing that longer preparation and integration sessions are linked to larger antidepressant effects in psilocybin-assisted therapy (1).

This finding underscores the importance of viewing psilocybin therapy not as a one-time event, but as a comprehensive process that requires careful planning and dedicated follow-up. The study, which analyzed data from seven randomized controlled trials involving 522 participants, provides valuable insights for both clinicians and individuals considering this form of treatment. The results are consistent with a 2024 study in the Journal of Psychiatric Research that also emphasizes the importance of psychological support in psychedelic therapy (2), and a 2025 meta-analysis in the Journal of Affective Disorders that points to the therapeutic relationship as a key factor in positive outcomes (3).

What is Preparation and Why is it So Important?

Preparation, in the context of psilocybin-assisted therapy, is the foundational work that is done before the psilocybin session. It is a collaborative process between the therapist and the client that involves establishing a strong therapeutic alliance, setting intentions for the psychedelic experience, and managing expectations. This phase is crucial for creating a sense of safety and trust, which is essential for navigating the often-intense emotional and psychological terrain of a psychedelic journey. The meta-analysis found that studies providing longer preparation sessions were associated with larger antidepressant effects, suggesting that this initial phase is a key determinant of therapeutic success (1).

What is Integration and How Does it Contribute to Healing?

Integration is the process of making sense of the psychedelic experience and incorporating its insights into one's daily life. It is a period of reflection, sense-making, and behavioral change that can last for weeks or even months after the dosing session. The goal of integration is to translate the profound and often ineffable insights of the psychedelic experience into lasting changes in one's thoughts, feelings, and behaviors. The meta-analysis found that longer integration sessions were also linked to larger antidepressant effects, highlighting the importance of this follow-up phase in consolidating the therapeutic gains of the psilocybin session (1).

What Does This Mean for the Future of Psychedelic Therapy?

The findings of this meta-analysis have significant implications for the future of psilocybin-assisted therapy. They highlight the need for standardized protocols that place a strong emphasis on both preparation and integration. The study also found that non-manualized psychotherapy, which allows for a more flexible and individualized approach, was associated with larger antidepressant effects. This suggests that a one-size-fits-all approach may not be the most effective way to deliver this therapy. As the field of psychedelic medicine continues to mature, it will be crucial to develop and refine therapeutic protocols that are both evidence-based and tailored to the unique needs of each individual.

Conclusion 

The journey of healing with psilocybin is not just about the psychedelic experience itself, but about the entire therapeutic process. By investing time and energy in both preparation and integration, individuals can significantly enhance the therapeutic benefits of this powerful medicine. If you are considering psilocybin-assisted therapy, it is essential to work with a qualified and experienced therapist who understands the importance of this comprehensive approach.

At Serenity Professional Counseling, we are committed to providing a safe, supportive, and evidence-based approach to psychedelic-assisted therapy. We understand that true healing requires more than just a single experience, which is why we place a strong emphasis on both preparation and integration. To learn more about our Psychedelic Therapy services and how we can support you on your journey, please visit our contact page to schedule a consultation. For more information on how psychedelics can help with specific conditions, you may find our blog post on Inner Journeys: How Meditation and Psychedelics Can Lead to Profound Insights and Well-Being to be a helpful resource.

About the Author

This article was written by Jeff Jones, a Licensed Professional Counselor (LPC) in Texas in practice 27 years. He is a 2024 graduate of the CIIS Center for Psychedelic Therapies and Research program. With a compassionate and evidence-based approach, he helps clients navigate life's challenges and find a path toward healing.

Disclaimer

The information in this article, including discussions of psychedelic-assisted psychotherapy, is for informational purposes only. Psychedelic-assisted psychotherapy has not been approved by all regulatory agencies in the United States, and its safety and efficacy are still being established. This content is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

(1) Syed, O. A., et al. (2026). Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 183, 106573. https://www.sciencedirect.com/science/article/pii/S014976342600028X

(2 ) Chisamore, N., et al. (2024). Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review. Journal of Psychiatric Research. https://www.sciencedirect.com/science/article/abs/pii/S0022395624003194

(3 ) Hultgren, J., et al. (2025). A dose of therapy with psilocybin - A meta-analysis on the role of the therapeutic component in psilocybin-assisted therapy for depression. Journal of Affective Disorders. https://www.sciencedirect.com/science/article/pii/S0163834325001562